A comparison of HDL and LDL cholesterol for prevalent coronary calcification

International Journal of Cardiology

Volumn 95, Issue 1, 2004, Pages 55-60

  Allison, Matthew A ^a   Wright, C Michael ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Cholesterol comparison; Coronary calcification

Indexed keywords

CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANAMNESIS; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY BUILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL;

AGED; BIOLOGICAL MARKERS; CALCINOSIS; CALIFORNIA; CARDIOMYOPATHIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; STATISTICS;

EID: 2442667451     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.04.013     Document Type: Article

References (34)

1. Sangiorgi G., Rumberger J.A., Edwards W.D., Gregoire J., Fitzpatrick L.A., Schwartz R.S. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J. Am. Coll. Cardiol. 31:1998;126-133
2. Mautner G.C., Mautner S.L., Froehlich J., Feuerstein I.M., Proschan M.A., Roberts W.C., et al. Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation. Radiology. 192:1994;619-623
3. Detrano R., Hsiai T., Wang S., et al. Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography. J. Am. Coll. Cardiol. 27:1996;1972-1978
4. Budoff M.J., Lane K.L., Bakhsheshi H., et al. Rates of progression of coronary calcium by electron beam tomography. Am. J. Cardiol. 86:2000;8-11
5. Achenbach S., Ropers D., Phole K., et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation. 106:2002;1077-1082
6. Yoon H.C., Emerick A.M., Hill J.A., Gjertson D.W., Goldin J.G. Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects. Radiology. 224:2002;236-241
7. Hecht H.S., Superko R.H., Smith K.L., McColgan B.P. Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment. Prev. Cardiol. 87:2001;406-412
8. Sacks F.M., Tonkin A.M., Shepherd J., et al. The effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors, The prospective pravastatin pooling project. Circulation. 102:2000;1893-1900
9. Castelli W.P., Doyle T.G., Harmes C.G., et al. HDL cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation. 55:1977;767-772
10. Von Eckardstein A., Nofer J.R., Assmann G. High density lipoproteins and atherosclerosis: role of cholesterol efflux and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 21:2001;13-27
11. Barter P.J., Rye K.A. High density lipoproteins and coronary heart disease. Atherosclerosis. 121:1996;1-12
12. PDAY Research Group Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the pathobiological determinants of atherosclerosis in youth research group. JAMA. 264:1990;3018-3024
13. Mahoney L.T., Burns T.L., Stanford W., et al. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the muscatine study. J. Am. Coll. Cardiol. 27:1996;277-284
14. Rubbins H.B., Robins S.J., Collins D., et al. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N. Engl. J. Med. 341:1999;410-418
15. Agatston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15:1990;827-832
16. Bard R., Kaminsky L.A., Whaley M.H., Zajakowski S. Evaluation of lipid profile measurements obtained from the Cholestech LDX analyser. J. Cardiopulm. Rehabil. 17:1997;413-418
17. Rogers E.J., Misner L., Ockene I.S., Nicolosi R.J. Evaluation of seven Cholestech LDX analysers for total cholesterol determinations. Clin. Chem. 39:1993;860-864
18. Arad Y., Spadaro L.A., Goodman K., et al. Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects. Circulation. 71:1996;369-377
19. Allison M.A., Wright C.M., Tiefenbrun J The correlation and predictive power of LDL cholesterol for coronary calcification as measured by electron beam computed tomography. Int. J. Cardiol. 96:2003;281-289
20. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the national cholesterol education program (NCEP) adult treatment panel III. JAMA. 285:2001;2486-2497
21. 2002 Heart and Stroke Statistical Update, American Heart Association, Available at http://www.amhrt.org.
22. NIH consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA. 269:1993;505-510
23. Castelli W.P., Doyle T.G., Hames C.G., et al. HDL cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation. 55:1977;767-772
24. Tall A.R. Plasma high density lipoproteins. J. Clin. Invest. 85:1990;1234-1241
25. Mackness M.I., Arrol S., Abbott C.A., Duringhton P.N. Protection of low-density lipoprotein associated paraoxonase. Atherosclerosis. 104:1993;129-135
26. Myers D.E., Huang W.N., Larkins R.G. Lipoprotein-induced prostacyclin production in endothelial cells and effects of lipoprotein modification. Am. J. Physiol. 271:1996;C1504-C1511
27. Von Eckardstein A., Nofer J.R., Assman G. Acceleration of reverse cholesterol transport. Curr. Opin. Cardiol. 15:2000;348-354
28. Osono Y., Woollett L.A., Marotti K.R., Melchior G.W., Dietschy J.M. Centripetal cholesterol flux from extrahepatic organs to the liver is independent of high density lipoprotein-cholesterol in plasma. Proc. Natl. Acad. Sci. U. S. A. 93:1996;4114-4119
29. Brown G., Albers J.J., Fisher L.D., et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med. 323:1990;1289-1298
30. Brown G., Zhao X.-Q., Chait A., et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N. Engl. J. Med. 345:2001;1583-1592
31. Assman G., Schulte H., von Eckardstein A., Huang Y. High density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. 124(S):1996;11-20
32. Parhami F., Morrow A.D., Balucan J., Leitinger N., Watson A.D., Tintut Y., et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: a possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol. 17:1997;680-687
33. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) adult treatment panel III. JAMA. 285:2001;2486-2497
34. Raggi P., Callister T.Q., Davidson M., Welty F.K., et al. Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial. Am. Heart J. 141:2001;722-726